.Common-Size Statement of Financial Position, Assets
Difficulty: Beginner
Allergan PLC, Common-Size Consolidated Statement of Financial Position, Assets
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| | Cash and cash equivalents | ||||||||||
| | Short-term investments | ||||||||||
| | Teva shares | ||||||||||
| | Marketable securities | % | | % | | % | | % | | % | |
| | Accounts receivable, net | ||||||||||
| | Inventories | ||||||||||
| | Prepaid taxes | ||||||||||
| | Prepaid insurance | ||||||||||
| | Royalty receivables | ||||||||||
| | Sales and marketing | ||||||||||
| | Other | ||||||||||
| | Prepaid expenses and other current assets | % | | % | | % | | % | | % | |
| | Current assets held for sale | ||||||||||
| | Deferred tax assets | ||||||||||
| | Current assets | % | | % | | % | | % | | % | |
| | Property, plant and equipment, net | ||||||||||
| | Legacy Allergan Deferred executive compensation investments | ||||||||||
| | Equity method investments | ||||||||||
| | Cost method investments | ||||||||||
| | Other long-term investments | ||||||||||
| | Taxes receivable | ||||||||||
| | Other assets | ||||||||||
| | Investments and other assets | % | | % | | % | | % | | % | |
| | Non current assets held for sale | ||||||||||
| | Deferred tax assets | ||||||||||
| | Product rights and other intangibles | ||||||||||
| | Goodwill | ||||||||||
| | Non current assets | % | | % | | % | | % | | % | |
| | Total assets | % | | % | | % | | % | | % | |
